首頁 › 癌症(所有類型) › 維吉尼亞州 › Charlottesville
Charlottesville, VA 的 癌症(所有類型) 臨床試驗
13 項針對 癌症(所有類型) 的研究正在 Charlottesville(約 30 英里範圍內)及其周邊地點尋找參與者。開啟研究以查看參與資格及聯絡研究團隊的方式。
官方研究文本(英文)
正在為研究招募對象嗎?將此頁面置頂展示 — $99 / 30 天 →
Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia
招募中3 期
- Quetzal Site 3, Charlottesville
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
招募中2/3 期
- University Of Virginia Health System, Charlottesville
RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
招募中2 期
- UVA Center for Psychiatric Clinical Research, Charlottesville
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
招募中3 期
- University of Virginia Health System, Charlottesville
Project: Every Child for Younger Patients With Cancer
招募中觀察性研究
- University of Virginia Cancer Center, Charlottesville
A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas
招募中1/2 期
- University of Virginia Health System, Charlottesville
FOG-001 in Locally Advanced or Metastatic Solid Tumors
招募中1/2 期
- University of Virginia, Charlottesville
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
招募中3 期
- University of Virginia Cancer Center, Charlottesville
Safety and Efficacy of Epcoritamab With Gemcitabine, Dexamethasone, and Cisplatin (GDP) Salvage Chemotherapy in Relapsed Refractory Large B-cell Lymphoma
招募中2 期
- University of Virginia Health System, Charlottesville
GEMINI-NSCLC: NSCLC Biomarker Study
招募中觀察性研究
- University of Virginia, Charlottesville
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
招募中觀察性研究
- Massive Bio SYNERGY-AI site, Charlottesville
A Study of NX-1607 in Adults With Advanced Malignancies
招募中1 期
- University of Virginia, Charlottesville
Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma
招募中
- University of Virginia Health System, Charlottesville
其他城市的 癌症(所有類型) 試驗
- Houston, TX121 項研究
- New York City, NY109 項研究
- Boston, MA85 項研究
- Los Angeles, CA74 項研究
- Nashville, TN65 項研究
- Philadelphia, PA59 項研究
- Washington, DC58 項研究
- Durham, NC58 項研究
- Chicago, IL51 項研究
- Atlanta, GA49 項研究
- Seattle, WA49 項研究
- Arlington, VA48 項研究
Charlottesville 的其他研究
- 非小細胞肺癌21 項研究
- 急性髓系白血病16 項研究
- 前列腺癌15 項研究
- 子宮內膜癌13 項研究
- 轉移性癌症13 項研究
- 肺癌13 項研究
- 心臟衰竭12 項研究
- 大腸直腸癌10 項研究
- 卵巢癌10 項研究
- 第一型糖尿病9 項研究
- 乳癌9 項研究
- 胰臟癌9 項研究
資料來源:ClinicalTrials.gov,擷取日期 2026年10月6日。各研究自行設定資格標準;由研究團隊決定參與者資格。